1. Respiratory distress 1-tachypnea (RR>60/min)
2-retraction ( subcostal – intercostal – suprasternal ) ↑ WOB
3-grunting
4-flaring of ala nasi
5-cyanosis
6-rales and wheezing

2. Cyanosis response to oxygen? Chest X ray?
Respiratory distress
Time of onset?
Cyanosis response to oxygen?
Chest X ray?

3. RDS risk factors prematurity, maternal diabetes perinatal asphyxia,
twin pregnancy,
cold stress,
precipitous labor,
cesarean delivery.
The incidence is highest in preterm male
or white infants.

4. Reduced risk of RDS The risk of RDS is reduced in pregnancies with:
chronic or pregnancy-associated hypertension,
maternal heroin use,
prolonged rupture of membranes, and
antenatal corticosteroid prophylaxis.

5. Pathophysiology lack of surfactant leads to progressive atelectasis,
V/Q mismatch, hypoxia, hypercapnia, respiratory and metabolic (lactic) acidosis, pulmonary hypertension, right to left shunting through ductus arteriosus and foramen ovale.

6. Pathology
the lungs of infants who die of RDS have a characteristic uniformly ruddy and airless appearance macroscopically resembling hepatic tissue. On microscopic examination the prominent finding is diffuse atelectasis and hyaline membrane.

9. Surfactant Therapy: Animal Models
Expansion patterns in lung sections of a newborn rabbit:
1a - after treatment with natural surfactant
1b - no treatment

10. Radiographic Changes With Exogenous Surfactant Treatment
before
after

11. Air bronchogram - ground glass apearance - hypoinflation

12. Survanta

13. Surfactant is present in high concentrations in fetal lung homogenates by 20 wk of gestation, but it does not reach the surface of the lungs until later.
It appears in amniotic fluid between 28 and 32 wk.
Mature levels of pulmonary surfactant
are usually present after 35 wk.
Synthesis of surfactant depends in part on normal pH, temperature, and perfusion.
Asphyxia, hypoxemia, and pulmonary
ischemia, particularly in association with hypovolemia, hypotension,and cold stress, may suppress surfactant synthesis.

14. Clinical manifestations
infants with RDS present at birth or within several hours after birth with clinical signs of respiratory distress including tachypnea, retraction, grunting, nasal flaring and cyanosis.
A late onset of tachypnea should suggest other conditions.

15. Clinical manifestations
Some patients require resuscitation at birth because of intrapartum asphyxia or initial severe respiratory distress (especially with a birthweight <1,000 g).
Cyanosis is relatively unresponsive to oxygen administeration.

16. Clinical manifestations
The natural course of untreated RDS is characterized by progressive worsening of cyanosis and dyspnea. If the condition is inadequately treated, blood pressure may fall; fatigue, cyanosis, and pallor increase, and grunting decreases or disappears as the condition worsens. Apnea and irregular respirations occur as infants tire and are ominous signs requiring immediate intervention. Patients may also have a mixed respiratory- metabolic acidosis, edema, ileus, and oliguria. Respiratory failure may occur in infants with rapid progression of the disease.

17. Clinical manifestations
In most cases, the symptoms and signs reach a peak within 3 days, after which improvement is gradual. Improvement is often heralded by spontaneous diuresis and the ability to oxygenate the infant at lower inspired oxygen levels or lower ventilator pressures.
Death is rare on the 1st day of illness, usually occurs between days 2 and 7, and is associated with alveolar air leaks (interstitial emphysema, pneumothorax), pulmonary hemorrhage, or IVH.
Mortality may be delayed weeks or months if BPD develops in mechanically ventilated infants with severe RDS.

18. Chest X Ray
the typical radiographic features (not pathognomonic) consist of a diffuse reticulogranular pattern giving the classic “ground-glass appearance” in both lung fields with superimposed airbronchograms and hypoaeration of the lung.

19. Differential diagnosis
in pneumonia manifested at birth, the chest roentgenogram may be identical to that for RDS. Maternal group B streptococcal colonization, organisms on Gram stain of gastric or tracheal aspirates or a buffy coat smear, and/or the presence of marked neutropenia may suggest the diagnosis of early-onset sepsis.
Cyanotic heart disease (total anomalous pulmonary venous return) can also mimic RDS both clinically and radiographically. Echocardiography with color flow imaging should be performed in infants who fail to respond to surfactant replacement to rule out cyanotic congenital heart disease as well as ascertain patency of the ductus arteriosus and assess pulmonary vascular resistance.

20. Differential diagnosis
Persistent pulmonary hypertension, aspiration (meconium, amniotic fluid) syndromes, spontaneous pneumothorax, pleural effusions, and congenital anomalies such as cystic adenomatoid malformation, pulmonary lymphangiectasia, diaphragmatic hernia, and lobar emphysema must be considered, but can generally be differentiated from RDS by roentgenographic evaluation.

21. PREVENTION
Avoidance of unnecessary or poorly timed cesarean section, appropriate management of high-risk pregnancy and labor, and prediction and possible in utero acceleration of pulmonary immaturity are important preventive strategies.
In timing cesarean section or induction of labor, estimation of fetal head circumference by ultrasonography and determination of the lecithin concentration in amniotic fluid by the lecithin:sphingomyelin ratio
(particularly useful with phosphatidylglycerol in diabetic pregnancies)
decrease the likelihood of delivering a premature infant.
Antenatal and intrapartum fetal monitoring may similarly decrease the risk of fetal asphyxia; asphyxia is associated with an increased incidence and severity of RDS.

22. PREVENTION
Administration of betamethasone to women 48 hr before the delivery of fetuses between 24 and 34 wk of gestation significantly reduces the incidence, mortality, and morbidity of RDS.
Corticosteroid administration is recommended for all women in preterm labor (24-34 wk gestation) who are likely to deliver a fetus within 1 wk.

23. PREVENTION
Prenatal glucocorticoid therapy decreases the severity of RDS and reduces the incidence of other compiications of prematurity, such as IVH, patent ductus arteriosus (PDA), pneumothorax, and necrotizing enterocolitis, without adversely affecting postnatal growth, lung mechanics or development, or the incidence of infection.
Prenatal glucocorticoids may act synergistically with postnatal exogenous surfactant therapy.

24. PREVENTION
Prenatal dexamethasone may be associated with a higher incidence of periventricular leukomalacia
than betamethasone.
The relative risk of RDS, IVH and death is higher with antenatal dexamethasone treatment when compared with betamethasone..
Administration of a 1st dose of surfactant into the trachea of symptomatic premature infants immediately after birth (prophylactic) or during the 1st few hours of life (early rescue) reduces air leak and mortality from RDS, but does not alter the incidence of BPD.

25. Treatment
The basic defect requiring treatment is inadequate pulmonary exchange of oxygen and carbon dioxide; metabolic acidosis and circulatory insufficiency are secondary manifestations.

26. Treatment
For the 1st 24 hr, 10% glucose and water should be infused through a peripheral vein at a rate of ml/kg/24 hr.
Excessive fluids (>140 cc/kg/day) contribute to the development of PDA and BPD.

27. Goal ABG
pao2=55-70,
paco2=45-55 and
pH=

28. Antibiotics should be started,
Because
pneumonia may present with the same clinical and radiological signs.

29. Dopamine should be started at 5-10mcg/kg/min
to support circulation in the case of hypotension. Relief of metabolic and respiratory acidosis by bicarbonate and assisted ventilation may cause a fall in blood pressure.

30. Surfactant
1- 3 doses of intratracheal surfactant in the first 48 hr of life .
The earlier the administration , the better the result.

31. Respiratory support
The goal of respiratory support is establishment of appropriate oxygen saturation (90 -95%) and ABG . Different levels of respiratory care : 1- oxygen via oxyhood 2-oxygen via nasal pronge 3- nasal CPAP 4- intubation and mechanical ventilation

32. Nasal prong
Oxyhood

33. Nasal CPAP
Oxygen mask

34. Respiratory failure PH< 7.2 PaCO2> 60 mmHg PaO2< 50 mmHg or
Frequent apnea
Despite inspiring 100% O2.

35. Other causes of respiratory distress
1-pneumonia
2-meconium aspiration
3- transient tachypnea of newborn
4-TE fistula
5-diaphragmatic paralysis
6-vocal cord paralysis
7-congenital diaphragmatic hernia
8- cystic adenomatoid malformation
9-bronchogenic cyst
10-congenital lobar emphysema
11-congenital heart disease
12-pulmonary lymphangiectasis
13- pneumothorax
14-PPHN
15-choanal atresia
16-pulmonary hypoplasia
17-pulmonary sequestration